How Funding Changes Functions
FDA Now More Focused on Drug Evaluation

As industry user fees have gone up, the percentage of total FDA resources devoted to human drug review has increased relative to all other FDA regulatory functions, including food safety, medical devices, blood products, and inspections.

The information in the graph shows in percentages how total agency resources are being divided between the drug review process and all other activities:

1992

drug review process: 17%
all other activities: 83%

1997

drug review process: 25%
all other activities: 75%

1999

drug review process: 28%
all other activities: 72%


Return to Main Article